Creative Planning - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102. A total of 31 filers reported holding NYMOX PHARMACEUTICAL CORP in Q2 2014. The put-call ratio across all filers is 5.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
Creative Planning ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2015$3,000
+200.0%
1,0000.0%0.00%
Q1 2015$1,0001,0000.0%0.00%
Q4 2014$0
-100.0%
1,0000.0%0.00%
Q3 2014$4,000
-20.0%
1,0000.0%0.00%
Q2 2014$5,0000.0%1,0000.0%0.00%
Q1 2014$5,000
-16.7%
1,0000.0%0.00%
Q4 2013$6,000
-14.3%
1,0000.0%0.00%
Q3 2013$7,000
+40.0%
1,0000.0%0.00%
Q2 2013$5,0001,0000.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q2 2014
NameSharesValueWeighting ↓
Advisors Asset Management, Inc. 1,148,396$8,912,0000.12%
WEDBUSH SECURITIES INC 207,526$174,0000.03%
MARATHON CAPITAL MANAGEMENT 55,000$46,0000.02%
Brown Advisory Securities, LLC 28,000$24,0000.01%
Virtu KCG Holdings LLC 30,635$26,0000.00%
GOFEN & GLOSSBERG LLC /IL/ 25,000$21,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 20,200$8,0000.00%
BANK OF MONTREAL /CAN/ 3,075$3,0000.00%
Citadel Advisors 32,075$27,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 10,800$9,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders